APO Research
Talk to an analyst

APO RESEARCH · REPORT

Seasonal Influenza Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Seasonal Influenza Vaccines Market Outlook and Growth Opportunities 2026

19 December 2025209 pages

Choose your research edition.

Industry ResearchSeasonal Influenza Vaccines Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Seasonal Influenza Vaccines Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Seasonal Influenza Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Seasonal Influenza Vaccines Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Seasonal Influenza Vaccines Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Seasonal Influenza Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Seasonal Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Seasonal Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Seasonal Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Seasonal Influenza Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Seasonal Influenza Vaccines market include Changsheng Bio-Technology, Sanofi, Novartis International AG, Merck & Co., Inc., Pfizer Inc, GlaxoSmithKline plc, AstraZeneca, Viatris Inc. and Vaxess Technologies Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Seasonal Influenza Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Seasonal Influenza Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Seasonal Influenza Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Seasonal Influenza Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Seasonal Influenza Vaccines Segment by Company

Changsheng Bio-Technology

Sanofi

Novartis International AG

Merck & Co., Inc.

Pfizer Inc

GlaxoSmithKline plc

AstraZeneca

Viatris Inc.

Vaxess Technologies Inc

Sinovac Biotech Ltd

SINOVAC

OSIVAX

Jiangsu Simcere Vaxtec Bio-pharmaceutical

EMERGEX VACCINES

EMERGENT

Dalian Hissen Bio-pharm

CSL Limited

Ccbio SA

Aleph Biomedical

Abbott Laboratories

Seasonal Influenza Vaccines Segment by Type

Type B

Type A (H3N2)

Type A (H1N1)

Seasonal Influenza Vaccines Segment by Application

Adults

Pediatrics

Elderly

Adolescence

Seasonal Influenza Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Seasonal Influenza Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Seasonal Influenza Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Seasonal Influenza Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Seasonal Influenza Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Seasonal Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Seasonal Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Seasonal Influenza Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Seasonal Influenza Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Seasonal Influenza Vaccines industry.

Chapter 3: Detailed analysis of Seasonal Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Seasonal Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Seasonal Influenza Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Seasonal Influenza Vaccines Industry Trends Table 2. Seasonal Influenza Vaccines Industry Drivers Table 3. Seasonal Influenza Vaccines Industry Opportunities and Challenges Table 4. Seasonal Influenza Vaccines Industry Restraints Table 5. Global Seasonal Influenza Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Seasonal Influenza Vaccines Revenue Share by Company (2021-2026) Table 7. Global Seasonal Influenza Vaccines Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Seasonal Influenza Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Seasonal Influenza Vaccines Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Seasonal Influenza Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Seasonal Influenza Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Seasonal Influenza Vaccines Company, Product Type & Application Table 13. Global Seasonal Influenza Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Seasonal Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Type B Table 18. Significant Companies of Type A (H3N2) Table 19. Significant Companies of Type A (H1N1) Table 20. Global Seasonal Influenza Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Seasonal Influenza Vaccines Sales Volume by Type (2021-2026) & (W Units) Table 22. Global Seasonal Influenza Vaccines Sales Volume by Type (2027-2032) & (W Units) Table 23. Global Seasonal Influenza Vaccines Sales Volume Share by Type (2021-2026) Table 24. Global Seasonal Influenza Vaccines Sales Volume Share by Type (2027-2032) Table 25. Global Seasonal Influenza Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Seasonal Influenza Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Seasonal Influenza Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Seasonal Influenza Vaccines Sales Value Share by Type (2021-2026) Table 29. Global Seasonal Influenza Vaccines Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Adults Table 31. Significant Companies of Pediatrics Table 32. Significant Companies of Elderly Table 33. Significant Companies of Adolescence Table 34. Global Seasonal Influenza Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 35. Global Seasonal Influenza Vaccines Sales Volume by Application (2021-2026) & (W Units) Table 36. Global Seasonal Influenza Vaccines Sales Volume by Application (2027-2032) & (W Units) Table 37. Global Seasonal Influenza Vaccines Sales Volume Share by Application (2021-2026) Table 38. Global Seasonal Influenza Vaccines Sales Volume Share by Application (2027-2032) Table 39. Global Seasonal Influenza Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Seasonal Influenza Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Seasonal Influenza Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Seasonal Influenza Vaccines Sales Value Share by Application (2021-2026) Table 43. Global Seasonal Influenza Vaccines Sales Value Share by Application (2027-2032) Table 44. Global Seasonal Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 45. Global Seasonal Influenza Vaccines Sales by Region (2021-2026) & (W Units) Table 46. Global Seasonal Influenza Vaccines Sales Market Share by Region (2021-2026) Table 47. Global Seasonal Influenza Vaccines Sales by Region (2027-2032) & (W Units) Table 48. Global Seasonal Influenza Vaccines Sales Market Share by Region (2027-2032) Table 49. Global Seasonal Influenza Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Seasonal Influenza Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Seasonal Influenza Vaccines Sales Value Share by Region (2021-2026) Table 52. Global Seasonal Influenza Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Seasonal Influenza Vaccines Sales Value Share by Region (2027-2032) Table 54. Global Seasonal Influenza Vaccines Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Seasonal Influenza Vaccines Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Seasonal Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. Global Seasonal Influenza Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units) Table 59. Global Seasonal Influenza Vaccines Sales Market Share by Country (2021-2026) Table 60. Global Seasonal Influenza Vaccines Sales by Country (2027-2032) & (W Units) Table 61. Global Seasonal Influenza Vaccines Sales Market Share by Country (2027-2032) Table 62. Global Seasonal Influenza Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Seasonal Influenza Vaccines Sales Value Market Share by Country (2021-2026) Table 64. Global Seasonal Influenza Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Seasonal Influenza Vaccines Sales Value Market Share by Country (2027-2032) Table 66. Changsheng Bio-Technology Company Information Table 67. Changsheng Bio-Technology Business Overview Table 68. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolio Table 70. Changsheng Bio-Technology Recent Development Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sanofi Seasonal Influenza Vaccines Product Portfolio Table 75. Sanofi Recent Development Table 76. Novartis International AG Company Information Table 77. Novartis International AG Business Overview Table 78. Novartis International AG Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Novartis International AG Seasonal Influenza Vaccines Product Portfolio Table 80. Novartis International AG Recent Development Table 81. Merck & Co., Inc. Company Information Table 82. Merck & Co., Inc. Business Overview Table 83. Merck & Co., Inc. Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Merck & Co., Inc. Seasonal Influenza Vaccines Product Portfolio Table 85. Merck & Co., Inc. Recent Development Table 86. Pfizer Inc Company Information Table 87. Pfizer Inc Business Overview Table 88. Pfizer Inc Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Pfizer Inc Seasonal Influenza Vaccines Product Portfolio Table 90. Pfizer Inc Recent Development Table 91. GlaxoSmithKline plc Company Information Table 92. GlaxoSmithKline plc Business Overview Table 93. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolio Table 95. GlaxoSmithKline plc Recent Development Table 96. AstraZeneca Company Information Table 97. AstraZeneca Business Overview Table 98. AstraZeneca Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. AstraZeneca Seasonal Influenza Vaccines Product Portfolio Table 100. AstraZeneca Recent Development Table 101. Viatris Inc. Company Information Table 102. Viatris Inc. Business Overview Table 103. Viatris Inc. Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Viatris Inc. Seasonal Influenza Vaccines Product Portfolio Table 105. Viatris Inc. Recent Development Table 106. Vaxess Technologies Inc Company Information Table 107. Vaxess Technologies Inc Business Overview Table 108. Vaxess Technologies Inc Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Vaxess Technologies Inc Seasonal Influenza Vaccines Product Portfolio Table 110. Vaxess Technologies Inc Recent Development Table 111. Sinovac Biotech Ltd Company Information Table 112. Sinovac Biotech Ltd Business Overview Table 113. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolio Table 115. Sinovac Biotech Ltd Recent Development Table 116. SINOVAC Company Information Table 117. SINOVAC Business Overview Table 118. SINOVAC Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. SINOVAC Seasonal Influenza Vaccines Product Portfolio Table 120. SINOVAC Recent Development Table 121. OSIVAX Company Information Table 122. OSIVAX Business Overview Table 123. OSIVAX Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. OSIVAX Seasonal Influenza Vaccines Product Portfolio Table 125. OSIVAX Recent Development Table 126. Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information Table 127. Jiangsu Simcere Vaxtec Bio-pharmaceutical Business Overview Table 128. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolio Table 130. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Development Table 131. EMERGEX VACCINES Company Information Table 132. EMERGEX VACCINES Business Overview Table 133. EMERGEX VACCINES Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. EMERGEX VACCINES Seasonal Influenza Vaccines Product Portfolio Table 135. EMERGEX VACCINES Recent Development Table 136. EMERGENT Company Information Table 137. EMERGENT Business Overview Table 138. EMERGENT Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. EMERGENT Seasonal Influenza Vaccines Product Portfolio Table 140. EMERGENT Recent Development Table 141. Dalian Hissen Bio-pharm Company Information Table 142. Dalian Hissen Bio-pharm Business Overview Table 143. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolio Table 145. Dalian Hissen Bio-pharm Recent Development Table 146. CSL Limited Company Information Table 147. CSL Limited Business Overview Table 148. CSL Limited Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. CSL Limited Seasonal Influenza Vaccines Product Portfolio Table 150. CSL Limited Recent Development Table 151. Ccbio SA Company Information Table 152. Ccbio SA Business Overview Table 153. Ccbio SA Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Ccbio SA Seasonal Influenza Vaccines Product Portfolio Table 155. Ccbio SA Recent Development Table 156. Aleph Biomedical Company Information Table 157. Aleph Biomedical Business Overview Table 158. Aleph Biomedical Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Aleph Biomedical Seasonal Influenza Vaccines Product Portfolio Table 160. Aleph Biomedical Recent Development Table 161. Abbott Laboratories Company Information Table 162. Abbott Laboratories Business Overview Table 163. Abbott Laboratories Seasonal Influenza Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Abbott Laboratories Seasonal Influenza Vaccines Product Portfolio Table 165. Abbott Laboratories Recent Development Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Seasonal Influenza Vaccines Distributors List Table 169. Seasonal Influenza Vaccines Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Seasonal Influenza Vaccines Product Image Figure 2. Global Seasonal Influenza Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Seasonal Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Seasonal Influenza Vaccines Sales (2021-2032) & (W Units) Figure 5. Global Seasonal Influenza Vaccines Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Seasonal Influenza Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Type B Image Figure 10. Type A (H3N2) Image Figure 11. Type A (H1N1) Image Figure 12. Global Seasonal Influenza Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Seasonal Influenza Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Seasonal Influenza Vaccines Sales Volume Share by Type (2021-2032) Figure 15. Global Seasonal Influenza Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Seasonal Influenza Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Seasonal Influenza Vaccines Sales Value Share by Type (2021-2032) Figure 18. Adults Image Figure 19. Pediatrics Image Figure 20. Elderly Image Figure 21. Adolescence Image Figure 22. Global Seasonal Influenza Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Seasonal Influenza Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Seasonal Influenza Vaccines Sales Volume Share by Application (2021-2032) Figure 25. Global Seasonal Influenza Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Seasonal Influenza Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Seasonal Influenza Vaccines Sales Value Share by Application (2021-2032) Figure 28. Global Seasonal Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 29. Global Seasonal Influenza Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Seasonal Influenza Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Seasonal Influenza Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Seasonal Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 33. North America Seasonal Influenza Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Seasonal Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Seasonal Influenza Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Seasonal Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Seasonal Influenza Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Seasonal Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 39. South America Seasonal Influenza Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Seasonal Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Seasonal Influenza Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Seasonal Influenza Vaccines Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Seasonal Influenza Vaccines Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Type B
  • Type A (H3N2)
  • Type A (H1N1)
Applications
  • Adults
  • Pediatrics
  • Elderly
  • Adolescence
Companies covered
  • Changsheng Bio-Technology
  • Sanofi
  • Novartis International AG
  • Merck & Co., Inc.
  • Pfizer Inc
  • GlaxoSmithKline plc
  • AstraZeneca
  • Viatris Inc.
  • Vaxess Technologies Inc
  • Sinovac Biotech Ltd
  • SINOVAC
  • OSIVAX
  • Jiangsu Simcere Vaxtec Bio-pharmaceutical
  • EMERGEX VACCINES
  • EMERGENT
  • Dalian Hissen Bio-pharm
  • CSL Limited
  • Ccbio SA
  • Aleph Biomedical
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Seasonal Influenza Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Seasonal Influenza Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Seasonal Influenza Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Seasonal Influenza Vaccines Market Dynamics
  1. 2.1 Seasonal Influenza Vaccines Industry Trends
  2. 2.2 Seasonal Influenza Vaccines Industry Drivers
  3. 2.3 Seasonal Influenza Vaccines Industry Opportunities and Challenges
  4. 2.4 Seasonal Influenza Vaccines Industry Restraints
3 Seasonal Influenza Vaccines Market by Company
  1. 3.1 Global Seasonal Influenza Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Seasonal Influenza Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Seasonal Influenza Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Seasonal Influenza Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Seasonal Influenza Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Seasonal Influenza Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Seasonal Influenza Vaccines Company Product Type and Application
  8. 3.8 Global Seasonal Influenza Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Seasonal Influenza Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Seasonal Influenza Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Seasonal Influenza Vaccines Market by Type
  1. 4.1 Seasonal Influenza Vaccines Type Introduction
  2. 4.1.1 Type B
  3. 4.1.2 Type A (H3N2)
  4. 4.1.3 Type A (H1N1)
  5. 4.2 Global Seasonal Influenza Vaccines Sales Volume by Type
  6. 4.2.1 Global Seasonal Influenza Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Seasonal Influenza Vaccines Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Seasonal Influenza Vaccines Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Seasonal Influenza Vaccines Sales Value by Type
  10. 4.3.1 Global Seasonal Influenza Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Seasonal Influenza Vaccines Sales Value by Type (2021-2032)
  12. 4.3.3 Global Seasonal Influenza Vaccines Sales Value Share by Type (2021-2032)
5 Seasonal Influenza Vaccines Market by Application
  1. 5.1 Seasonal Influenza Vaccines Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Pediatrics
  4. 5.1.3 Elderly
  5. 5.1.4 Adolescence
  6. 5.2 Global Seasonal Influenza Vaccines Sales Volume by Application
  7. 5.2.1 Global Seasonal Influenza Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Seasonal Influenza Vaccines Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Seasonal Influenza Vaccines Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Seasonal Influenza Vaccines Sales Value by Application
  11. 5.3.1 Global Seasonal Influenza Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Seasonal Influenza Vaccines Sales Value by Application (2021-2032)
  13. 5.3.3 Global Seasonal Influenza Vaccines Sales Value Share by Application (2021-2032)
6 Seasonal Influenza Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Seasonal Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Seasonal Influenza Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Seasonal Influenza Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Seasonal Influenza Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Seasonal Influenza Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Seasonal Influenza Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Seasonal Influenza Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Seasonal Influenza Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Seasonal Influenza Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Seasonal Influenza Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Seasonal Influenza Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Seasonal Influenza Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Seasonal Influenza Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Seasonal Influenza Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Seasonal Influenza Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Seasonal Influenza Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Seasonal Influenza Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Seasonal Influenza Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Seasonal Influenza Vaccines Sales Value Share by Country, 2025 VS 2032
7 Seasonal Influenza Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Seasonal Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Seasonal Influenza Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Seasonal Influenza Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Seasonal Influenza Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Seasonal Influenza Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Seasonal Influenza Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Seasonal Influenza Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Seasonal Influenza Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Seasonal Influenza Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Seasonal Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Seasonal Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Changsheng Bio-Technology
  2. 8.1.1 Changsheng Bio-Technology Company Information
  3. 8.1.2 Changsheng Bio-Technology Business Overview
  4. 8.1.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolio
  6. 8.1.5 Changsheng Bio-Technology Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Seasonal Influenza Vaccines Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Novartis International AG
  14. 8.3.1 Novartis International AG Company Information
  15. 8.3.2 Novartis International AG Business Overview
  16. 8.3.3 Novartis International AG Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis International AG Seasonal Influenza Vaccines Product Portfolio
  18. 8.3.5 Novartis International AG Recent Developments
  19. 8.4 Merck & Co., Inc.
  20. 8.4.1 Merck & Co., Inc. Company Information
  21. 8.4.2 Merck & Co., Inc. Business Overview
  22. 8.4.3 Merck & Co., Inc. Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck & Co., Inc. Seasonal Influenza Vaccines Product Portfolio
  24. 8.4.5 Merck & Co., Inc. Recent Developments
  25. 8.5 Pfizer Inc
  26. 8.5.1 Pfizer Inc Company Information
  27. 8.5.2 Pfizer Inc Business Overview
  28. 8.5.3 Pfizer Inc Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Inc Seasonal Influenza Vaccines Product Portfolio
  30. 8.5.5 Pfizer Inc Recent Developments
  31. 8.6 GlaxoSmithKline plc
  32. 8.6.1 GlaxoSmithKline plc Company Information
  33. 8.6.2 GlaxoSmithKline plc Business Overview
  34. 8.6.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolio
  36. 8.6.5 GlaxoSmithKline plc Recent Developments
  37. 8.7 AstraZeneca
  38. 8.7.1 AstraZeneca Company Information
  39. 8.7.2 AstraZeneca Business Overview
  40. 8.7.3 AstraZeneca Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 AstraZeneca Seasonal Influenza Vaccines Product Portfolio
  42. 8.7.5 AstraZeneca Recent Developments
  43. 8.8 Viatris Inc.
  44. 8.8.1 Viatris Inc. Company Information
  45. 8.8.2 Viatris Inc. Business Overview
  46. 8.8.3 Viatris Inc. Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Viatris Inc. Seasonal Influenza Vaccines Product Portfolio
  48. 8.8.5 Viatris Inc. Recent Developments
  49. 8.9 Vaxess Technologies Inc
  50. 8.9.1 Vaxess Technologies Inc Company Information
  51. 8.9.2 Vaxess Technologies Inc Business Overview
  52. 8.9.3 Vaxess Technologies Inc Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Vaxess Technologies Inc Seasonal Influenza Vaccines Product Portfolio
  54. 8.9.5 Vaxess Technologies Inc Recent Developments
  55. 8.10 Sinovac Biotech Ltd
  56. 8.10.1 Sinovac Biotech Ltd Company Information
  57. 8.10.2 Sinovac Biotech Ltd Business Overview
  58. 8.10.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolio
  60. 8.10.5 Sinovac Biotech Ltd Recent Developments
  61. 8.11 SINOVAC
  62. 8.11.1 SINOVAC Company Information
  63. 8.11.2 SINOVAC Business Overview
  64. 8.11.3 SINOVAC Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 SINOVAC Seasonal Influenza Vaccines Product Portfolio
  66. 8.11.5 SINOVAC Recent Developments
  67. 8.12 OSIVAX
  68. 8.12.1 OSIVAX Company Information
  69. 8.12.2 OSIVAX Business Overview
  70. 8.12.3 OSIVAX Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 OSIVAX Seasonal Influenza Vaccines Product Portfolio
  72. 8.12.5 OSIVAX Recent Developments
  73. 8.13 Jiangsu Simcere Vaxtec Bio-pharmaceutical
  74. 8.13.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
  75. 8.13.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Business Overview
  76. 8.13.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolio
  78. 8.13.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
  79. 8.14 EMERGEX VACCINES
  80. 8.14.1 EMERGEX VACCINES Company Information
  81. 8.14.2 EMERGEX VACCINES Business Overview
  82. 8.14.3 EMERGEX VACCINES Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 EMERGEX VACCINES Seasonal Influenza Vaccines Product Portfolio
  84. 8.14.5 EMERGEX VACCINES Recent Developments
  85. 8.15 EMERGENT
  86. 8.15.1 EMERGENT Company Information
  87. 8.15.2 EMERGENT Business Overview
  88. 8.15.3 EMERGENT Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 EMERGENT Seasonal Influenza Vaccines Product Portfolio
  90. 8.15.5 EMERGENT Recent Developments
  91. 8.16 Dalian Hissen Bio-pharm
  92. 8.16.1 Dalian Hissen Bio-pharm Company Information
  93. 8.16.2 Dalian Hissen Bio-pharm Business Overview
  94. 8.16.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolio
  96. 8.16.5 Dalian Hissen Bio-pharm Recent Developments
  97. 8.17 CSL Limited
  98. 8.17.1 CSL Limited Company Information
  99. 8.17.2 CSL Limited Business Overview
  100. 8.17.3 CSL Limited Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 CSL Limited Seasonal Influenza Vaccines Product Portfolio
  102. 8.17.5 CSL Limited Recent Developments
  103. 8.18 Ccbio SA
  104. 8.18.1 Ccbio SA Company Information
  105. 8.18.2 Ccbio SA Business Overview
  106. 8.18.3 Ccbio SA Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Ccbio SA Seasonal Influenza Vaccines Product Portfolio
  108. 8.18.5 Ccbio SA Recent Developments
  109. 8.19 Aleph Biomedical
  110. 8.19.1 Aleph Biomedical Company Information
  111. 8.19.2 Aleph Biomedical Business Overview
  112. 8.19.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Aleph Biomedical Seasonal Influenza Vaccines Product Portfolio
  114. 8.19.5 Aleph Biomedical Recent Developments
  115. 8.20 Abbott Laboratories
  116. 8.20.1 Abbott Laboratories Company Information
  117. 8.20.2 Abbott Laboratories Business Overview
  118. 8.20.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Abbott Laboratories Seasonal Influenza Vaccines Product Portfolio
  120. 8.20.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Seasonal Influenza Vaccines Value Chain Analysis
  2. 9.1.1 Seasonal Influenza Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Seasonal Influenza Vaccines Sales Mode & Process
  6. 9.2 Seasonal Influenza Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Seasonal Influenza Vaccines Distributors
  9. 9.2.3 Seasonal Influenza Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst